Els van de Vijver

143 Holtman GA, Lisman-van Leeuwen Y, Day AS, Fagerberg UL, Henderson P, Leach ST, Perminow G, Mack D, van Rheenen PF, van de Vijver E , Wilson DC, Reitsma JB, Berger MY. Use of Laboratory Markers in Addition to Symptoms for Diagnosis of Inflammatory Bowel Disease in Children: A Meta-analysis of Individual Patient Data. JAMA Pediatr. 2017 Oct 1;171(10):984-991. Heida A, Van de Vijver E , Muller Kobold A, van Rheenen P. Selecting children with suspected inflammatory bowel disease for endoscopy with the calgranulin C or calprotectin stool test: protocol of the CACATU study. BMJ Open. 2017 May 29;7(5):e015636. Alves MM, Halim D, Maroofian R, de Graaf BM, Rooman R, van der Werf CS, Van de Vijver E , Mehrjardi MY, Aflatoonian M, Chioza BA, Baple EL, Dehghani M, Crosby AH, Hofstra RM. Genetic screening of Congenital Short Bowel Syndrome patients confirms CLMP as the major gene involved in the recessive form of this disorder. Eur J Hum Genet. 2016 Nov;24(11):1627-1629. Degraeuwe PL, Beld MP, Ashorn M, Canani RB, Day AS, Diamanti A, Fagerberg UL, Henderson P, Kolho KL, Van de Vijver E , van Rheenen PF, Wilson DC, Kessels AG. Faecal calprotectin in suspected paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2015 Mar;60(3):339-46. Verhulst SL, Van de Vijver E . An adolescent with recurrent cough and vomiting. J Paediatr Child Health. 2015 Nov;51(11):1139, 1140 Hindryckx P, Amininejad L, Van De Vijver E , Bossuyt P; Belgian Group for IBD Research and Development. Belgian recommendations for the management of anemia in patients with inflammatory bowel disease. Acta Gastroenterol Belg. 2014 Sep;77(3):333-44. Sabato V, Van De Vijver E , Hagendorens M, Vrelust I, Reyniers E, Fransen E, Bridts C, De Clerck L, Mortier G, Valent P, Ebo D. Familial hypertryptasemia with associated mast cell activation syndrome. List of Publications 143